105 related articles for article (PubMed ID: 12895296)
1. Gene therapy for mice sarcoma with oncolytic herpes simplex virus-1 lacking the apoptosis-inhibiting gene, icp34.5.
Lan P; Dong C; Qi Y; Xiao G; Xue F
J Biochem Mol Biol; 2003 Jul; 36(4):379-86. PubMed ID: 12895296
[TBL] [Abstract][Full Text] [Related]
2. Immune analysis on mtHSV mediated tumor therapy in HSV-1 seropositive mice.
Zhu H; Su Y; Zhou S; Xiao W; Ling W; Hu B; Liu Y; Qi Y
Cancer Biol Ther; 2007 May; 6(5):724-31. PubMed ID: 17592250
[TBL] [Abstract][Full Text] [Related]
3. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted therapy with a conditionally replicating mutant of HSV-1 induces regression of xenografted human hepatomas.
Xue F; Dong CY; Su Y; Zhu H; Ling W; Liu Y; Xu H; Xiao W; Zhou S; Qi YP
Cancer Biol Ther; 2005 Nov; 4(11):1234-9. PubMed ID: 16357508
[TBL] [Abstract][Full Text] [Related]
5. Rasgrp2 regulates the permissiveness of NIH3T3 cells to a herpes simplex virus 1 mutant with inactivated ICP34.5 gene.
Xiao W; Su Y; Zhou S; Yi Ch; He G; Liu Y; Qi Y
Acta Virol; 2013; 57(1):41-9. PubMed ID: 23530823
[TBL] [Abstract][Full Text] [Related]
6. Direct intratumoral gene transfer of the herpes simplex virus thymidine kinase gene with DNA-liposome complexes: growth inhibition of tumors and lack of localization in normal tissues.
Takakuwa K; Fujita K; Kikuchi A; Sugaya S; Yahata T; Aida H; Kurabayashi T; Hasegawa I; Tanaka K
Jpn J Cancer Res; 1997 Feb; 88(2):166-75. PubMed ID: 9119745
[TBL] [Abstract][Full Text] [Related]
7. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
8. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
11. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported.
Inagaki T; Satoh M; Fujii H; Yamada S; Shibamura M; Yoshikawa T; Harada S; Takeyama H; Saijo M
Jpn J Infect Dis; 2018 Sep; 71(5):343-349. PubMed ID: 29848849
[TBL] [Abstract][Full Text] [Related]
13. Genotypic and phenotypic characterization of the thymidine kinase of ACV-resistant HSV-1 derived from an acyclovir-sensitive herpes simplex virus type 1 strain.
Saijo M; Suzutani T; De Clercq E; Niikura M; Maeda A; Morikawa S; Kurane I
Antiviral Res; 2002 Dec; 56(3):253-62. PubMed ID: 12406508
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
Coukos G; Makrigiannakis A; Kang EH; Rubin SC; Albelda SM; Molnar-Kimber KL
Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
[TBL] [Abstract][Full Text] [Related]
15. Augmented therapeutic efficacy of an oncolytic herpes simplex virus type 1 mutant expressing ICP34.5 under the transcriptional control of musashi1 promoter in the treatment of malignant glioma.
Kanai R; Tomita H; Hirose Y; Ohba S; Goldman S; Okano H; Kawase T; Yazaki T
Hum Gene Ther; 2007 Jan; 18(1):63-73. PubMed ID: 17238803
[TBL] [Abstract][Full Text] [Related]
16. Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system.
Hayashi K; Hayashi T; Sun HD; Takeda Y
Hum Gene Ther; 2002 Feb; 13(3):415-23. PubMed ID: 11860708
[TBL] [Abstract][Full Text] [Related]
17. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
18. Thymidine Kinase-Negative Herpes Simplex Virus 1 Can Efficiently Establish Persistent Infection in Neural Tissues of Nude Mice.
Huang CY; Yao HW; Wang LC; Shen FH; Hsu SM; Chen SH
J Virol; 2017 Feb; 91(4):. PubMed ID: 27974554
[TBL] [Abstract][Full Text] [Related]
19. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of bystander effect of herpes simplex virus thymidine kinase/acyclovir system using fluorescence resonance energy transfer technique.
Xiong T; Li Y; Ni F; Zhang F
J Biomed Nanotechnol; 2012 Feb; 8(1):74-9. PubMed ID: 22515095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
